Patent Application
20180119166
The present invention relates to a nucleic acid molecule encoding a Gle1 protein variant with increased sensitivity to phytic acid, a protein coded by the nucleic acid molecule, and a use and method of the protein for improving a seed yield, promoting germination and growth or increasing abiotic stress tolerance in phytate-deficient plants.
Myo-inositol-1,2,3,4,5,6-hexakisphosphate (InsP6), known as phytic acid, is the major form of phosphorous in plant seeds, and provided as a reservoir for phosphate, minerals and inositol to support seed germination and seedling growth (Raboy, 2003, 2009; Munnik and Nielsen, 2011). However, high contents of phytic acid in cereal grains and legumes have been known to cause nutritional and environmental problems (Raboy, 2001, 2009; Brinch-Pedersen et al., 2006; Beardsley, 2011). Phytic acid is a strong chelator of cations of a mineral such as iron, zinc or calcium, forming stable salts called phytins. Phytins are indigestible to humans and nonruminant animals and mostly excreted, resulting in mineral deficiency. The inability to use the phosphorous of phytic acid resulted in increased feed costs for pigs, poultry and fish because they need to supplement phosphorous for proper growth.
In addition, the excretion of undigested InsP6 in animal waste is an important cause of water pollution. Thus, the phytic acid of seeds has a very adverse effect on the nutrition and environment for humans and animals.
To improve the nutritional quality of crops, low-phytic acid (lpa) mutants of maize, barley, wheat, rice and soybeans have been isolated, and they are mutated in myo-inositol-3-phosphate synthase (MIPS), myo-inositol kinase (MIK), inositol polyphosphate kinase (IPK), and multidrug resistance-associated (MRP) ATP-binding cassette transporter genes (Raboy et al., 2000; Meis et al., 2003; Shi et al., 2003, 2005, 2007; Bregitzer and Raboy, 2006; Murphy et al., 2008; Raboy, 2009). However, such mutants frequently showed undesirable crop characteristics such as reduced seed yield and weight, poor seed germination and stunted vegetative growth. Accordingly, to reduce adverse effects of the low-phytic acid mutation, seed-targeted low-phytic acid engineering has recently been attempted using seed-specific promoters (Shi et al., 2007; Kuwano et al., 2009; Ali et al., 2013; Li et al., 2014). Despite such attempts, high yield low-phytate crops have not yet been commercialized (Tillie et al., 2013).
InsP6 is very abundant in eukaryotic cells, and involved in various cellular processes. In yeast and mammals, InsP6 has been known to be involved in mRNA export, translational control, RNA editing, and DNA repair (Hanakahi and West, 2002; Macbeth et al., 2005; Bolger et al., 2008; Montpetit et al., 2011). In plants, InsP6 is present as a storage form (phytate) in seeds and has been associated with hormonal and signal transduction processes. InsP6 stimulates Ca2+ export in guard cells in response to abscisic acid, inducing stomatal closure (Lemtiri-Chlieh et al., 2003). InsP6 was identified by the X-ray crystal structure of the auxin receptor TIR, probably as a structural cofactor (Tan et al., 2007). However, the detailed function and significance of InsP6 signaling in plant development have not yet been revealed.
The inventors have previously reported that a nuclear pore protein Rae1 (yeast Gle2p) plays a dual role in plants, in relation to mRNA export in interphase and in spindle assembly in mitosis (Lee et al., 2009). This result is consistent with recent findings in which a nuclear pore complex (NPC) protein performs a function besides the role as a structural component for NPC (Blower et al., 2005; Jeganathan et al., 2005; Orjalo et al., 2006; Franks and Hetzer, 2013; Vollmer and Antonin, 2014). To identify plant NPC proteins with atypical functions, the inventors performed screening for the phenotypes of Nicotiana benthamiana NPC genes using virus-induced gene silencing (VIGS), and ploidy analysis using N. benthamiana Rae1 and Nup96 (involved in auxin signaling) as controls.
The VIGS for most of the tested genes showed a slightly mild phenotype in N. benthamiana, which means that partial gene silencing cannot make the genes lose their cellular functions. However, VIGS of Gle1 caused more visible phenotypes including growth arrest and abnormal leaf development without affecting the ploidy level of leaves. Gle1 is an essential multifunctional protein that is highly conserved from yeast to humans. In yeast, Gle1 and its cofactor InsP6 activate DEAD-box ATPase Dbp5 for nuclear mRNA export in the NPC (Alcet et al., 2006, 2010; Dossani et al., 2009; Montpetit et al., 2011). Gle1 is also found in the cytosol, and plays a role in translation initiation and termination in Dbp5-independent and -dependent manners (Bolger et al., 2008; Kutay and Panse, 2008). In plants, the cellular functions of Gle1 were not known except that T-DNA insertion mutation of Gle1 of Arabidopsis causes an embryonic lethal phenotype (Braud et al., 2012). In the present invention, the inventors showed the cellular function of Gle1 in plants in relation to LOS4 and InsP6, and suggested that a strategy for overcoming adverse effects of the low-phytic acid characteristic using Gle1 variants.
Throughout this specification, a number of theses and patent documents are provided as references and cited references thereof are shown. The disclosure of the cited theses and patent literatures are incorporated herein by reference in its entirety, and thus the level of the field of art including the present application and the scope of the present application are more fully described.
The inventors have tried to develop a novel method for solving problems of low seed productivity and low germination frequency, which are found in low-InsP6-containing crops. As a result, it was identified that InsP6 serves to control mRNA export as a cofactor of Gle1 in plants, and confirmed that Gle1 variants with increased affinity to InsP6 allow mRNA export to normally occur in low-InsP6-containing plants, resulting in effectively rescuing low growth and low yields shown in low-InsP6-containing plants, and thus completed the present invention.
Therefore, the present invention is directed to providing a nucleic acid molecule encoding a Gle1 protein variant.
The present invention is also directed to providing a Gle1 protein variant coded by the nucleic acid molecule.
The present invention is also directed to providing a gene delivery system which comprises the nucleic acid molecule.
The present invention is also directed to providing a composition for increasing seed yield, germination, growth, or abiotic stress tolerance in plants comprising the gene delivery system.
The present invention is also directed to providing plant cells and/or a plant, which is transformed by the gene delivery system.
The present invention is also directed to providing a method of increasing seed yield, promoting germination and growth or increasing abiotic stress tolerance in plants.
Other objects and advantages of the present invention will be more clearly explained with reference to detailed description, claims and drawings of the present invention as follows.
In one aspect, the present invention provides a nucleic acid molecule encoding a Gle1 protein variant, wherein a Gle1 protein comprising a phytic acid-binding pocket represented by General Formula 1,
Leu-Leu-Ala-Glu-Xaa1-Xaa2-Xaa3-Xaa4-Cys-Xaa5-Tyr-Thr-Val-Pro [General Formula 1]
(wherein Xaa1 is Leu or Phe, Xaa2 is His or Asn, Xaa3 is Lys or Arg, Xaa4 is Ala or Val, and Xaa5 is Ile or Met)
wherein the Gle1 protein variant comprising the phytic acid-binding pocket of General Formula 1 in which one or more residues selected from the group consisting of the Xaa4 residue and the Glu residue is substituted with a basic amino acid.
The inventors have attempted to develop a novel method for solving problems such as low seed productivity and germination frequency, shown in low-InsP6-containing crops. As a result, it was identified that InsP6 serves to control mRNA export as a cofactor of Gle1 in plants, and confirmed that Gle1 variants with increased affinity to InsP6 allow mRNA export to normally occur in low-InsP6-containing plants, resulting in effectively rescuing low growth and low yields. In addition, the inventors have reported that Gle1-InsP6 serves as an activator of LOS4 ATPase/RNA helicase involved in mRNA export in plants, supporting the Gle1-InsP6-Dbp5 (LOS4 homolog) paradigm proposed in yeast.
According to the present invention, Arabidopsis thaliana Gle1 variants with mutations that increase the basic charge on an InsP6-binding surface show increased sensitivity to InsP6 concentrations with respect to the stimulation of LOS4 ATPase activity in vitro, and expression of the Gle1 variants with the increased InsP6 sensitivity rescues the mRNA export defect in an ipk1 InsP6-deficient mutant, and highly increases vegetative growth, seed yield and seed performance of the mutants.
In the present invention, according to alignment of amino acid residues of the InsP6-binding pocket of the Gle1 domain in the Gle1 protein (
The plants may be dicotyledonous plants or monocotyledonous plants. In addition, the dicotyledonous plants comprise Arabidopsis thaliana (At) and Glycine max (Gm). In addition, the monocotyledonous plants comprise Oryza sativa (Os), Zea mays (Zm), Hordeum vulgare (Hv), Triticum aestivum (Ta) and Sorghum bicolor (Sb).
The term “nucleic acid molecule” used herein broadly encompasses DNA and RNA molecules. Nucleotides which are basic components of the nucleic acid molecule comprise analogs having modified sugar moieties or base moieties as well as natural nucleotides (Scheit, Nucleotide Analogs, John Wiley, New York (1980); Uhlman and Peyman, Chemical Reviews, 90:543-584 (1990)). The “nucleic acid molecule” used herein is interchangeably used with “polynucleotide.”
The term “nucleic acid sequence” used herein refers to the sequence of nucleotides which are the basic components of the nucleic acid molecule.
There are mutations in nucleotides, which do not result in changes in proteins. The nucleic acid molecule of the present invention comprises functionally equivalent codons, codons coding for the same amino acids (e.g., due to codon degeneracy, six codons for arginine or serine), or codons coding for biologically equivalent amino acids.
In consideration of the above-described mutations with biologically equivalent activities, the nucleic acid molecule used in the present invention is interpreted to comprise sequences with substantial identity to the sequences set forth in the sequence listing. The sequences with substantial identity refer to sequences that are aligned to correspond as much as possible to a random sequence different from the above-described sequence of the present invention, and have preferably at least 60%, more preferably 70%, further more preferably 80%, and most preferably 90% homology when being analyzed using an algorithm conventionally used in the art. Alignment methods for sequence comparison are well known in the art. Various methods and algorithms for alignment are disclosed in Smith and Waterman, Adv. Appl. Math. 2:482 (1981) Needleman and Wunsch, J. Mol. Bio. 48:443 (1970); Pearson and Lipman, Methods in Mol. Biol. 24: 307-31 (1988); Higgins and Sharp, Gene 73:237-44 (1988); Higgins and Sharp, CABIOS 5:151-3 (1989); Corpet et al., Nuc. Acids Res. 16:10881-90 (1988); Huang et al., Comp. Appl. BioSci. 8:155-65 (1992) and Pearson et al., Meth. Mol. Biol. 24:307-31 (1994). The National Center for Biological Information (NBCI) basic local alignment search tool (BLAST) (Altschul et al., J. Mol. Biol. 215:403-10 (1990)) is accessible from NBCI or the like, and can be used in combination with sequencing programs such as blastp, blasm, blastx, tblastn and tblastx on the Internet. BLSAT is accessible at http://www.ncbi.nlm.nih.gov/BLAST/. A method of comparing sequence homology using this program can be found at http://www.ncbi.nlm.nih.gov/BLAST/blast_help.html.
According to an exemplary embodiment of the present invention, a nucleic acid molecule of the present invention may encode a Gle1 protein variant comprising a phytic acid-binding pocket of General Formula 1 in which one or more residues selected from the group consisting of Xaa4 and Glu residues in is substituted with a basic amino acid. Preferably, the nucleic acid molecule of the present invention may encode a Gle1 protein variant comprising a phytic acid-binding pocket of General Formula 1 in which the Xaa4 residue is substituted with a basic amino acid, or the nucleic acid molecule may encode Gle1 protein variants comprising a phytic acid-binding pocket of General Formula 1 in which both of the Glu and Xaa4 residues are respectively substituted with basic amino acids.
According to another exemplary embodiment of the present invention, in the amino acid sequence of the InsP6-binding pocket, represented by General Formula 1, comprised in the preferable Gle1 protein, Xaa1 may be Leu, Xaa2 may be His, Xaa3 may be Arg, Xaa4 may be Ala, and Xaa5 may be Ile. The Gle1 protein including the InsP6-binding pocket of the sequence may be derived from legumes (soybeans, Glycine max, etc.). Accordingly, the nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant including an InsP6-binding pocket in which the 4th residue (Glu) and/or the 8th residue (Ala) in an amino acid sequence of SEQ ID NO: 13 is/are substituted with basic amino acid(s). The nucleic acid molecule of the present invention may also comprise a nucleic acid sequence encoding a Gle1 protein variant in which Glu 447 and/or Ala 451 in the amino acid sequence (XP_006591482) of the Gle1 protein of Glycine max is/are substituted with basic amino acid(s).
According to an exemplary embodiment of the present invention, in the amino acid sequence of the InsP6-binding pocket, represented by General Formula 1, comprised in the preferable Gle1 protein, Xaa1 may be Phe, Xaa2 may be His, Xaa3 may be Arg, Xaa4 may be Val, and Xaa5 may be Met. The Gle1 protein including the InsP6-binding pocket of the sequence may be derived from rice (Oryza sativa). Accordingly, the nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant including an InsP6-binding pocket in which the 4th residue (Glu) and/or the 8th residue (Val) in an amino acid sequence of SEQ ID NO: 14 is/are substituted with basic amino acid(s). The nucleic acid molecule of the present invention may comprise a nucleic acid sequence encoding a Gle1 protein variant in which Glu 542 and/or Val 546 in an amino acid sequence (Os; EEC73520.1) of the Gle1 protein of Oryza sativa is/are substituted with basic amino acid(s).
According to another exemplary embodiment of the present invention, in the amino acid sequence of the InsP6-binding pocket, represented by General Formula 1, comprised in the preferable Gle1 protein, Xaa1 may be Phe, Xaa2 may be Asn, Xaa3 may be Arg, Xaa4 may be Val, and Xaa5 may be Ile. The Gle1 protein including the InsP6-binding pocket of the sequence may be derived from maize (Zea mays). Accordingly, the nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant including an InsP6-binding pocket in which the 4th residue (Glu) and/or the 8th residue (Val) in an amino acid sequence of SEQ ID NO: 15 is/are substituted with basic amino acid(s). The nucleic acid molecule of the present invention may comprise a nucleic acid sequence encoding a Gle1 protein variant in which Glu 455 and/or Val 459 in the amino acid sequence (Zm; AFW67255.1) of the Gle1 protein of Zea mays is/are substituted with basic amino acid(s).
According to still another exemplary embodiment of the present invention, in the amino acid sequence of the InsP6-binding pocket, represented by General Formula 1, included in the preferable Gle1 protein, Xaa1 may be Phe, Xaa2 may be Asn, Xaa3 may be Lys, Xaa4 may be Val, and Xaa5 may be Met. The Gle1 protein including the InsP6-binding pocket of the sequence may be derived from barley (Hordeum vulgare) or wheat (Triticum aestivum). Accordingly, the nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant including an InsP6-binding pocket in which the 4th residue (Glu) and/or the 8th residue (Val) in any one of the amino acid sequences of SEQ ID NO: 16 and 17 is/are substituted with basic amino acid(s). In addition, the nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant including an InsP6-binding pocket in which Glu 436 and/or Val 440 in the amino acid sequence (Hv; BAJ99175.1) of the Gle1 protein of Hordeum vulgare is/are substituted with basic amino acid(s). The nucleic acid molecule of the present invention may comprise a nucleic acid sequence encoding a Gle1 protein variant in which Glu 438 and/or Val 442 in the amino acid sequence (Ta; W5GX62) of the Gle1 protein of Triticum aestivum is/are substituted with basic amino acid(s).
According to yet another exemplary embodiment of the present invention, in the amino acid sequence of the InsP6-binding pocket, represented by General Formula 1, included in the preferable Gle1 protein, Xaa1 may be Phe, Xaa2 may be His, Xaa3 may be Lys, Xaa4 may be Ala, and Xaa5 may be Ile. The Gle1 protein including the InsP6-binding pocket of the sequence may be derived from Arabidopsis. The nucleic acid molecule of the present invention comprises a nucleic acid sequence encoding a protein variant in which Glu 433 and/or Ala 447 in a sequence set forth in SEQ ID NO: 2 is/are substituted with basic amino acid(s). The nucleic acid molecule of the present invention preferably comprises a nucleic acid sequence encoding a protein variant in which the Aka 437 residue, or the Glu 433 residue and the Ala 437 residue is/are substituted with basic amino acid(s).
In the present invention, an acidic or neutral amino acid residue of the InsP6-binding pocket of the Gle1 protein is substituted with a basic amino acid to increase the sensitivity of the Gle1 protein in plants and thus improve the growth of low-phytate plants. The basic amino acid used in the present invention may achieve the same effect using Lys, Arg or His, and preferably Lys.
In another aspect, the present invention provides Gle1 protein variants coded by the above-described nucleic acid molecules of the present invention, respectively.
The Gle1 protein variant coded by the above-described nucleic acid molecules of the present invention also comprises Gle1 protein variants of different plant species as long as the variants elevate the sensitivity of the Gle1 protein in plants by substituting a specific amino acid (acidic or neutral) residue with a basic amino acid on the basis of the highly-conserved sequence of the InsP6-binding pocket of the Gle1 protein.
In still another aspect, the present invention provides gene delivery systems including the above-described Gle1 protein variant-encoding nucleic acid molecule.
The gene delivery system may be a recombinant vector for plant expression.
According to another exemplary embodiment of the present invention, the gene delivery system is a recombinant vector for plant expression, which comprises (a) the Gle1 protein variant-encoding nucleic acid molecule of the present invention described above; (b) a promoter operatively linked to the nucleic acid molecule and forming an RNA molecule in plant cells; and (c) a poly A signal sequence acting in plant cells to cause polyadenylation at the 3′ end of the RNA molecule.
The term “operatively linked” refers to functional binding between a nucleic acid expression regulatory sequence (e.g., an array of a promoter, a signal sequence, or an array of transcriptional regulatory factor-binding sites) and a different nucleic acid sequence, and therefore, the regulatory sequence regulates transcription and/or translation of the different nucleic acid sequence.
A vector system of the present invention may be constructed by various methods known in the art, and a specific method for constructing the vector system is disclosed in Sambrook et al. Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press (2001).
The suitable promoter used in the present invention may be any one conventionally used in the art for the introduction of a gene to a plant, and comprises, for example, a seed or embryo-specific promoter (Ole or Glb promoter), a SP6 promoter, a T7 promoter, a T3 promoter, a PM promoter, a maize ubiquitin promoter, a cauliflower mosaic virus (CaMV) 35S promoter, a nopaline synthase (nos) promoter, a Figwort mosaic virus 35S promoter, a sugarcane bacilliform virus promoter, a commelina yellow mottle virus promoter, a photo-inducible promoter of a small subunit of ribulose-1,5-bis-phosphate carboxylase (ssRUBISCO), a cytosolic triosphosphate isomerase (TPI) promoter in rice, or an adenine phosphoribosyltransferase (APRT) or octopine synthase promoter in Arabidopsis.
According to still another exemplary embodiment of the present invention, the suitable poly A signal sequence causing 3′-end polyadenylation in the present invention comprises the nos 3′-end derived from the nopaline synthase gene of Agrobacterium tumefaciens (Bevan et al. Nucleic Acids Research, 11(2):369-385 (1983)), the ocs 3′-end derived from the octopine synthase gene of Agrobacterium tumefaciens, the 3′ end region of the protease I or II gene of tomatoes or potatoes, or a CaMV 35S terminator or octopine synthase (OCS) terminator sequence.
Optionally, the vector additionally delivers genes encoding reporter molecules (e.g., luciferase and β-glucuronidase). In addition, the vector of the present invention comprises an antibiotic (e.g., neomycin, carbenicillin, kanamycin, spectinomycin, hygromycin, etc.)-resistant gene (e.g., neomycin phosphotransferase (npt II), hygromycin phosphotransferase (hpt), etc.) as a selectable marker.
According to another exemplary embodiment of the present invention, the recombinant vector for plant expression of the present invention is an Agrobacterium binary vector.
The term “binary vector” used herein refers to a vector divided into two plasmids consisting of a plasmid having a left border (LB) and a right border (RB), which are necessary for mobility in a tumor inducible (Ti) plasmid, and a plasmid containing genes necessary for transferring target nucleotides. The Agrobacterium for transformation of the present invention may be any one that is suitable for the expression of the nucleotide sequence of the present invention, and particularly, the Agrobacterium strain for plant transformation in the present invention is preferably Agrobacterium tumefaciens C58C1.
A method of introducing the recombinant vector of the present invention into Agrobacterium may be performed by various methods known in the art, including, for example, particle bombardment, electroporation, transfection, a lithium acetate method and heat shock.
In the present invention, abiotic stress comprises dry stress, low-temperature stress, or salt stress, and more preferably salt stress. According to the present invention, the inventors confirmed that Gle1 variant seeds retain normal sensitivity to the salt stress.
In yet aspect, the present invention provides a composition for increasing seed yield, germination, growth, or abiotic stress tolerance in plants, which includes the above-described gene delivery system containing the above-described nucleic acid molecule encoding the Gle1 protein variant of the present invention as an active ingredient.
The composition may be used to change the phenotype of a plant by introducing a gene or nucleic acid molecule into the plant.
According to an exemplary embodiment of the present invention, the plant is preferably an InsP6-deficient plant. When InsP6 is contained at a low concentration in the plant, a problem of unfavorable plant growth occurs. Therefore, when the nucleic acid molecule of the present invention that can encode the Gle1 protein variant of the present invention is introduced into such InsP6-deficient plant, the seed yield of the InsP6-deficient plant may be increased, the germination and growth may be promoted, or the tolerance to abiotic stress may be increased.
In yet another aspect, the present invention provides transgenic plant cells into which the nucleic acid molecule of the present invention is introduced. The plant cells may be transformed by the gene delivery system of the present invention.
In yet another aspect, the present invention provides a transgenic plant into which the nucleic acid molecule of the present invention is introduced. The plant may be transformed by the gene delivery system of the present invention. To prepare the transgenic plant cells and transgenic plant of the present invention, a method generally known in the art (Methods of Enzymology, Vol. 153, (1987)) may be used. A plant may be transformed by inserting an exogenous polynucleotide into a delivery system such as a plasmid or virus vector. To this end, Agrobacterium bacteria may be used as a mediator (Chilton et al. Cell 11:263:271 (1977)), or an exogenous polynucleotide may be directly introduced into plant cells (Lorz et al. Mol. Genet. 199:178-182; (1985)). For example, electroporation, microparticle bombardment, or polyethylene glycol-mediated uptake may be used when a vector without a T-DNA site is used.
Generally, for plant transformation, methods of infecting plant cells or seeds with Agrobacterium tumefaciens transformed with an exogenous polynucleotide are widely used (U.S. Pat. Nos. 5,004,863, 5,349,124 and 5,416,011). Transgenic plant cells or seeds may be cultured under suitable conditions known to those of ordinary skill in the art to grow plants.
It is construed that the term “plant(s)” used herein comprises all of mature plants, and plant cells, plant tissues and plant seeds that can be grown to mature plants.
When the nucleic acid molecule of the present invention is introduced or applied to plants, compared to a wild type, sensitivity and binding strength with respect to plant InsP6 may be improved, and thus the transgenic plant is improved in growth efficiency, seed yield, germination frequency and stress tolerance. Particularly, even in an environment containing a low concentration of InsP6, the sensitivity to InsP6 is maintained at a high level, the growth, seed yield, germination frequency and/or abiotic stress tolerance of plants may be improved or increased.
The plant to which the method of the present invention may be applied is not particularly limited. Plants to which the method of the present invention is applied may comprise almost all of dicotyledonous plants including lettuce, napa cabbage, potatoes and white radishes and monocotyledonous plants including rice, barley, banana, etc. Particularly, when the method of the present invention is applied to edible vegetables or fruits exhibiting a rapid deterioration of quality by aging due to thin skins, like tomatoes; and plants having leaves as main products for commerce, it is effective in increasing storage efficiency. The present invention is preferably applied to plants selected from the group consisting of food crops including rice, wheat, barley, maize, beans, potatoes, red bean, oat, and sorghum; vegetable crops including Arabidopsis, napa cabbage, white radish, peppers, strawberry, tomatoes, watermelon, cucumber, cabbage, oriental melon, pumpkin, welsh onion, onion, and carrot; special crops including ginseng, tobacco, cotton, sesame, sugar cane, sugar beet, perilla, peanut and canola; fruit trees including apple, pear, jujube, peach, kiwi, grape, tangerine, persimmon, plum, apricot and banana trees; flowers including rose, gladiolus, gerbera, carnation, chrysanthemum, lily and tulip; and feed crops including ryegrass, red clover, orchardgrass, alfalfa, tall fescue and perennial ryegrass. More preferably, the plants are rice, wheat, barley, maize, legume, potato, red bean, oat, sorghum or Arabidopsis, and further more preferably, the plants are rice, wheat, barley, maize, legume, sorghum or Arabidopsis.
According to an exemplary embodiment of the present invention, the plant may be an InsP6-deficient plant. When the nucleic acid molecule of the present invention is introduced into an InsP6-deficient plant, it was experimentally confirmed that the growth, seed yield, germination frequency and/or abiotic stress tolerance of the plant is improved.
The term “InsP6-deficient plants” comprise identified or unidentified low-phytic acid (lpa) mutants, and for example, the InsP6-deficient plants are plants containing an inactivated myo-inositol-3-phosphate synthase (MIPS) gene, myo-inositol kinase (MIK), inositol polyphosphate kinase (IPK) gene or multidrug resistance-associated (MRP) ATP-binding cassette transporter gene, but the present invention is not limited thereto. In the specification, this term is interchangeably used with “low-InsP6 plants.”
The term “inactivation” use herein refers to a state in which a gene is mutated to prevent the generation of a functional protein that will be produced when the gene is expressed.
For example, an inactivated MIK gene comprises an imperfect form of a protein coded by the MIK gene, a form with imperfect activity, a truncated form or non-formation of a protein. The inactivation comprises inhibition of the functional expression of one or more genes. Gene inactivation may comprise deletion, disruption of a protein-coding sequence, insertion, addition, substitution, mutation or seed-specific gene silencing (e.g., RNAi).
Additionally, the term “inactivity” used herein is induced by the above-described “inactivation.” According to some exemplary embodiments, due to the inactivated gene, a measurable change in the activity of a gene or a gene product may not be shown. According to some exemplary embodiments, the functional expression of a gene may not be shown or slightly shown by the inactivated gene.
In yet another aspect, the present invention provides a method of increasing seed yield, promoting germination and growth or increasing abiotic stress tolerance in plants, which comprises increasing InsP6 sensitivity of the Gle1 protein in plants.
That is, the present invention provides a method of increasing seed yield, promoting germination or growth, or increasing abiotic stress tolerance, which comprises introducing a gene delivery system containing a Gle1 protein variant-encoding nucleic acid molecule of the present invention into plants.
The method may further comprise selecting a transgenic plant exhibiting the phenotype with increased seed yield, germination performance, growth performance or abiotic stress tolerance compared to a wild type.
The plants comprise all of mature plants, and plant cells, plant tissue and plant seeds that can be grown to mature plants, and details on the plants other than the types of the plants are the same as described above.
The transgenic plant into which the nucleic acid molecule of the present invention is introduced has an ability to be grown in a stress environment where the content of InsP6 is very low. That is, the transgenic plant may have higher growth activity, seed germination frequency and seed yield, or higher tolerance to abiotic stresses than the wild type due to increased sensitivity to InsP6 even in an environment in which InsP6 is present at a low content. Particularly, when the InsP6-deficient plant is transformed using the nucleic acid molecule of the present invention, it has an excellent effect of increasing seed yield, promoting germination or growth, or increasing abiotic stress tolerance of the plant. The inventors examined plant growth at a low InsP6 concentration after a plant was transformed by the Gle1 protein variant-encoding nucleic acid molecule of the present invention. As a result, it was experimentally confirmed that the transgenic plant of the present invention is more excellent in growth activity than comparative groups.
A method of introducing target nucleotides or a recombinant vector for plant expression containing the same into plant cells may be performed by various methods known in the art.
Selection of the transgenic plant cells may be performed by exposing the transgenic culture to a selection agent (e.g., a metabolic inhibitor, an antibiotic and an herbicide). Plant cells which stably contain a marker gene providing tolerance to a selection agent are grown in one culture and then divided. Exemplary markers comprise a hygromycin phosphotransferase gene, a glycophosphate-resistant gene and a neomycin phosphotransferase (nptII) system, but the present invention is not limited thereto. A method of developing or redifferentiating a plant from a plant protoplasts or various explants are well known in the art. The development or redifferentiation of the plant containing a foreign gene introduced by Agrobacterium may be achieved according to a method known in the art (U.S. Pat. Nos. 5,004,863, 5,349,124 and 5,416,011).
The nucleotide, plant expression vector and the transforming method thereof, which are used in the present invention, have been described above, and thus the descriptions will be omitted without avoiding excessive complexity of the specification due to repeated descriptions.
The above and other objects, features and advantages of the present invention will become more apparent to those of ordinary skill in the art by describing in detail exemplary embodiments thereof with reference to the accompanying drawings, in which:
Hereinafter, the present invention will be described in further detail with reference to examples. The examples are merely provided to more fully describe the present invention, and it will be obvious to those of ordinary skill in the art that the scope of the present invention is not limited to the following examples.
[Experimental Methods]
Experimental Method 1. Plant Materials and Growth Conditions
Arabidopsis thaliana (ecotype Columbia-0) plants were grown in a growth chamber at 22° C. and 150 μmol m−2s−1 under a 16-h-light/8-h-dark cycle. The ipk1-1 (SALK_065337) and los4-1 (CS24938) mutants were obtained from Salk (www.salk.edu/) and ABRC (https://abrc.osu.edu/), respectively. N. benthamiana plants, a tobacco species, were grown in a growth room at 22° C. and 80 μmol m−2s−1 under a 16-h-light/8-h-dark cycle.
Experimental Method 2. Seed Germination Assay
Seeds were sterilized and sown on a medium containing a Murashige and Skoog (MS) salt including vitamins and 0.8% phytoagar with or without addition of NaCl (100 and 200 mM), sucrose (150 and 250 mM) or mannitol (200 and 400 mM). Before sowing, seeds imbibed for 3 days at 4° C. The seeds were incubated on a medium at 4° C. for 1 day after sowing, and then transferred to a growth chamber (22° C., continuous light condition). Seed germination was recorded when cotyledon emergence was visible.
Experimental Method 3. In Situ Hybridization of Poly(A) RNA
In situ hybridization of poly(A) RNA was performed using a 45-nucleotide oligo (dT) probe labeled with Cy3 at its end as described by Lee et al. (2009). Cy3 fluorescence was detected with a confocal laser scanning microscope (CFLSM, Zeiss LSM 510).
Experimental Method 4. Western Blotting
Anti-Gle1 antibodies against two oligopeptides, EEARRKERAHQEEK and MRLYGALVQT, which correspond to amino acid residues 228 to 241 and 465 to 474 of Arabidopsis Gle1, respectively, were produced in rabbits using the antibody production service of Cosmogenetech (http://www.cosmogenetech.com). Western blotting was performed using mouse monoclonal antibodies against Myc tag (1:5,000, ABM) or Flag tag (1:10,000, Sigma-Aldrich), a rabbit polyclonal antibody against Gle1 (1:1,000, Cosmogenetech) or a goat polyclonal antibody against GFP (1:5,000, ABM). Subsequently, the membrane was treated with a horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG antibody (1:5000, Invitrogen), a goat anti-rabbit IgG antibody (1:10,000, Invitrogen), or a donkey anti-goat antibody (1:10,000, Santa Cruz Biotechnology). Signals were detected by ImageQuant LAS 4000 (GE Healthcare Life Sciences).
Experimental Method 5. ATPase Assay
A steady-state ATPase assay was performed as described by Alcet et al. (2006) with slight modifications. The ATPase assay was performed with a LOS4-His protein in a 96-well plate using a buffer containing 20 mM HEPES (pH 7.5), 150 mM NaCl, 3 mM MgCl2, 1 mM DTT, 2 mM ATP, 6 mM phosphoenolpyruvate, 1.2 mM NADH, 1 mg/ml BSA and 2% (v/v) pyruvate kinase/lactate dihydrogenase (Sigma-Aldrich) in a total volume of 100 μl. Polyadenylic acid was added at 50 μg/ml or different concentrations as described above. Absorbance at 340 nm was measured using a VersaMax absorbance microplate reader (Molecular Devices), and the data were analyzed using SoftMax Pro software (Molecular Devices).
Experimental Method 6. Nucleic Acid-Melting Assay
A nucleic acid-melting assay was performed as described by Kim et al. (2007) using 78-nucleotide-long, 9-bp-containing, hairpin-shaped molecular beacons conjugated with a fluorophore (tetramethylrhodamine) and a quencher (Dabcyl). Spectrofluorometry was performed using a fluorescence spectrophotometer (Hitachi F-2000) at an excitation wavelength of 555 nm and an emission wavelength of 575 nm.
Experimental Method 7. Generation of Arabidopsis Dexamethasone (DEX)-Inducible Gle1 RNAi Lines
For Gle1 (N) RNAi lines, a 356-bp Gle1 cDNA fragment was amplified by PCR using 5′-atggggattgttttggaac-3′ (3rd sequence) and 5′-ggttcatgatcaaactcttcat-3′ (4th sequence) primers, which contained XhoI and HindIII sites for a sense construct and SpeI and EcoRI sites for an antisense construct. For Gle1 (C) RNAi lines, a 330-bp Gle1 cDNA fragment was amplified by PCR using 5′-cacaaagcttgcatttacact-3′ (5th sequence) and 5′-atgctctctcacaacattcac-3′ (6th sequence) primers, which contained XhoI and ClaI sites for a sense construct and SpeI and BamHI sites for an antisense construct. Using these constructs, DEX-inducible Gle1RNAi Arabidopsis lines were generated as described by Ahn et al. (2011). For induction of RNAi, the transgenic seedling was grown on a medium containing 10 NM DEX in ethanol (0.033%). Alternatively, the RNAi seedling was sprayed with 30 μM DEX in ethanol (0.033%) and Tween 20 (0.01% w/v).
Experimental Method 8. Virus-Induced Gene Silencing (VIGS)
VIGS was performed in N. benthamiana as described by Lee et al. (2009); Ahn et al. (2011); and Cho et al. (2013).
Experimental Method 9. Agrobacterium-Mediated Transient Expression
Agroinfiltration was performed as described by Ahn et al. (2011) and Cho et al. (2013).
Experimental Method 10. Real-Time Quantitative RT-PCR
Real-time quantitative RT-PCR was performed as described by Ahn et al. (2011) and Cho et al. (2013) using the following primers: 5′-catggatgggcttggttagc-3′ (7th sequence) and 5′-tgtcgcagtggctctgttg-3′ (8th sequence) for detecting Gle1 transcripts in RNAi-Gle1 (N) lines, 5′-tcagccaattactaacacaacctt-3′ (9th sequence) and 5′-gacatgcattacaaatcctcca-3′ (10th sequence) for detecting Gle1 transcripts in RNAi-Gle1 (C) lines, and 5′-atgggtccttcagagagtcct-3′ (11th sequence) and 5′-tggaacaccttggtcctaaag-3′ (12th sequence) for detecting UBC10 transcripts.
Experimental Method 11. Measurement of Chlorophyll Contents
Chlorophylls were extracted from N. benthamiana as described by Terry and Kendrick (1999). Spectrofluorometry was performed using a fluorescence spectrophotometer (Hitachi F-2000) at an excitation wavelength of 440 nm and an emission wavelength of 600-700 nm as described by Terry and Kendrick (1999).
Experimental Method 12. Immunolabeling of Tobacco BY-2 Cells
Immunocytochemical staining of BY-2 cells was performed as described by Lee et al. (2009). For double-labeling of Gle1 and α-tubulin, BY-2 cells were fixed, permeabilized, and immunolabeled with anti-Gle1 (rabbit polyclonal) antibodies (1:200; Cosmogenetech) and anti-α-tubulin (mouse monoclonal) antibodies (1:1,000; Sigma-Aldrich). Afterward, the cells were incubated with Alexa Fluor 563-conjugated anti-rabbit IgG antibodies (1:1,000; Invitrogen) and Alexa Fluor 488-conjugated anti-mouse IgG antibodies (1:1,000; Invitrogen). After brief staining with DAPI, the BY-2 cells were observed with a confocal laser scanning microscope (CFLSM, Zeiss LSM 510).
Experimental Method 13. Co-Immunoprecipitation
Flag-Gle1 and LOS4-Myc fusion proteins were coexpressed in Nicotiana benthamiana by agroinfiltration. Co-immunoprecipitation was performed following the manufacturer's instructions using the ANTI-FLAGM2 Affinity Gel (Sigma-Aldrich). After elution with a 3× FLAG peptide (F4799, Sigma-Aldrich), proteins were subjected to SDS-PAGE and western blotting.
Experimental Method 14. Purification of Recombinant Proteins
Gle1 and Gle1C (aa residues 244-611) were cloned into a pMAL C2X vector (New England Biolabs) for MBP fusion, LOS4 was cloned into a pET-29a vector for His fusion. MBP-Gle1 and MBP-Gle1C proteins were expressed in a BL21 (DE3) strain, and LOS4-His proteins were expressed in a Rosseta (DE3) strain of Escherichia coli. Cells were grown at 37° C. to an A600 of 0.4, shifted to 16° C., and induced by 0.25 mM IPTG for 16 hours. The MBP- and His-fusion proteins were purified following the manufacturer's introductions using MBP Excellose (Bioprogen) and His60 Ni Superflow™ resin (Clontech), respectively.
Experimental Method 15. In Vitro Pull-Down Assay
MBP and MBP-Gle1 proteins immobilized on MBP Excellose (Bioprogen) were incubated with LOS4-His proteins for 2 hours at room temperature. Similarly, LOS4-His proteins immobilized on a His60 Ni Superflow™ resin (Clontech) were incubated with MBP or MBP-Gle1 for 2 hours at room temperature. After extensive washing of the resins, the bound proteins were eluted with 2×SDS sample buffer, and the eluted proteins were visualized by Coomassie blue staining.
Experimental Method 16. HPIC
Seed extracts were prepared from mature dry seeds as described by Stevenson-Paulik et al. (2005) with slight modifications. Approximately 15 mg of seeds and 15 mg of acid-washed glass beads (425 to 600 mm; Sigma-Aldrich) were mixed with 20 volumes of 0.4 M HCl. Samples were pulverized using a Mini-BeadBeater 16 (BioSpec Products) for 5 minutes and then boiled for 5 minutes. Samples were pulverized again for 5 minutes and seed extracts were collected by centrifugation for 10 minutes at 15,000 g. The extracts were passed through filters (PTFE, 0.2 μm; Whatman) and analyzed by HPIC (ICS-3000; Dionex) as described by Kim and Tai, 2011 with slight modifications. An IonPac AS11 anion exchange column (4×250 mm; Dionex) was eluted with a linear gradient of NaOH from 5 to 80 mM under a flow rate of 1 mL/min for 70 minutes at 35° C. A conductivity detector was used with an electrolytically regenerated suppressor (ERS 500; Dionex) operated with the external water mode at a current of 300 mA. Inositol phosphate was purchased from Sigma-Aldrich, and a standard curve was established for the quantification. All of the measurements were performed in triplicate and expressed as mean±SD.
Experimental Method 17. Statistical Analysis
Two-tailed Student's t-tests were performed using the Minitab 16 program (Minitab Inc.; http://www.minitab.com/en-KR/default.aspx) to determine the statistical differences between the samples.
[Experimental Results]
Experimental Result 1. Gle1 Silencing Resulted in Growth Retardation and mRNA Export Defects in Arabidopsis and N. benthamiana
Multispecies sequence alignment revealed that Gle1 is generally found in eukaryotes, and conserved from yeast to humans and plants, particularly, in the Gle1 domain (
After hybridization with a 45-nucleotide oligo (dT) probe labeled with Cy3 (Cy3-oligo-dT) at its end, poly(A) RNA signals were broadly distributed in the cytosol and nuclei in (−)DEX leaf cells. Meanwhile, (+)DEX leaves accumulated much stronger poly(A) RNA signals in the nuclei, indicating that mRNA export from the nucleus to the cytosol was distributed by Gle1 defects (
VIGS was performed in N. benthamiana with two constructs NbGle1 (N) and NbGle1 (C) containing a 615-bp N-terminal and 570-bp C-terminal region of Gle1 cDNA, respectively (
Experimental Result 2. Gle1 Localized in Nuclear Envelope and Cytosol
The inventors examined the subcellular localization of Gle1 by expressing a GFP fusion protein of Arabidopsis Gle1 (GFP-Gle1) in N. benthamiana using agroinfiltration. Confocal laser scanning microscopy of mesophyll protoplasts and the epidermal cells of a leaf showed that Gle1 is enriched around the nuclear envelope and in the cytosol (
Experimental Result 3. Gle1 Interacts with DEAD-Box ATPase LOS4
It has been reported that Gle1 associates with the DEAD-box ATPase/RNA helicase Dbp5 and Nup159 to form an mRNA-exporting module in yeast (Montpetit et al., 2011). The Arabidopsis homolog of yeast Dbp5 is LOS4 (low expression of osmotically responsive genes 4), which plays a critical role in expression of a cold stress-responsive gene and tolerance to chilling and freezing stresses of plants (Gong et al., 2002, 2005). The los4-1 mutant plants exhibited growth retardation under normal growth conditions (
Experimental Result 4. Gle1 Stimulates ATPase Activity of LOS4
To explore the functional relationship between Gle1 and LOS4, the inventors measured LOS4 ATPase activity in the absence or presence of Gle1. First, the inventors purified LOS-His, MBP-Gle1, and the MBP fusion protein of the carboxyl-terminal domain of Gle1 (MBP-Gle1C; amino acid residues 244-611) (
LOS4 belongs to the DEAD-box RNA helicase gene family in Arabidopsis, and its yeast homolog Dbp5 has ATP-dependent RNA helicase activity (Tseng et al., 1998; Gong et al., 2005). To test whether Gle1 activates the RNA helicase activity of LOS4, the inventors performed an in vitro nucleic acid-melting assay with LOS4-His and MBP-Gle1 (full length) recombinant proteins using 78 nucleotide-long, 9-bp-containing, hairpin-shaped molecular beacons (
Experimental Result 5. Plant Gle1 Proteins have Modifications in Several Key Residues in InsP6-Binding Pocket.
Recently, the structure of a Dbp5-InsP6-Gle1 complex of yeast was resolved by protein crystallography, which indicates that InsP6 stabilizes the interaction between Gle1 and Dbp5 by acting as a small-molecule tether (Montpetit et al., 2011). InsP6 binding to a positively-charged pocket at the interface between Gle1 and C-terminal domain of Dbp5; residues K264, K333, H337, R374, K377 and K378 of Gle1, and K477 and K481 of Dbp5 are involved in the interaction with the phosphate group of InsP6 (Montpetit et al., 2011). Particularly, the two resides K377 and K378 of yeast Gle1 were identified as critical residues for InsP6 binding according to site-directed mutagenesis (Alcet et al., 2010). Computational modeling predicted the surface potential of the Arabidopsis and human Gle1 domain based on that of the yeast Gle1 domain (
Arabidopsis Gle1 residues corresponding to the R374, K377, and K378 residues of yeast Gle1 could be clearly identified due to high homology around the residues (
Experimental Result 6. Gle1 (IS1) and Gle1 (IS2) Variants Show Increased Sensitivity to InsP6 Concentration for Stimulation of LOS4 ATPase Activity
First, the inventors determined whether the Gle1-dependent stimulation of LOS4 ATPase activity is influenced by the presence of InsP6 (
Next, the inventors tested whether the Gle1 variants with a modified InsP6-binding pocket have different sensitivity to InsP6 in the stimulation of the LOS4 ATPase activity. The Gle1 variants, such as Gle1C (IS1), Gle1C (IS2) and Gle1C (ID), were generated by site-directed mutagenesis, and MBP fusion proteins of such mutants were expressed and purified in E. coli (
Experimental Result 7. Expression of InsP6-Sensitive Gle1 Variants Improves Vegetative Growth of Ipk1 InsP6 Biosynthetic Mutants
Then, the inventors investigated whether the Gle1 (IS1) and Gle1 (IS2) variants functioned better in a low InsP6 background in vivo than wild type Gle1 by testing their abilities to complement the ipk1-1 mutation in Arabidopsis. IPK1 encodes inositol 1,3,4,5,6-pentakisphosphate 2-kinase, which is an enzyme that catalyzes the final step of InsP6 biosynthesis, the conversion of InsP5 to InsP6 (Stevenson-Paulik et al., 2005; Monserrate and York, 2010; Munnik and Nielsen, 2011). The ipk1-1T-DNA inserted mutant of Arabidopsis showed considerably reduced InsP6 levels, about 17% and 7.5% of wild type levels in seeds and seedlings, respectively, and had growth defects which became serious in a nutrient-rich condition (Stevenson-Paulik et al., 2005). To express Gle1 variants in the ipk1-1 background using Agrobacterium tumefaciens-mediated transformation, the inventors introduced GFP fusion constructs of wild type Gle1 (GFP-Gle1), Gle1 (IS1)[GFP-IS1], and Gle1 (IS2)[GFP-IS2] into the ipk1-1 mutant under the control of a CaMV35S promoter. Confocal microscopy showed that GFP-IS1 and GFP-IS2 were localized in the nuclear envelope and the cytosol like GFP-Gle1 (
Compared to the parental ipk1-1 mutant, the transgenic GFP-IS1 and GFP-IS2 lines showed significant improvement in vegetative growth with an increase in the size and greening of leaves and a decrease in the necrosis at the leaf margins, although the leaf curling phenotype still remained (
Based on such a result, the inventors questioned whether the growth defect mainly occurs due to improperly functioning Gle1 because the growth defect of the ipk1-1 mutants is due to a InsP6 defect. Therefore, the inventors tested whether the ipk1-1 mutant has mRNA export defects through in situ hybridization (
Experimental Result 8. InsP6-Sensitive Gle1 Variants Improves Seed Yield and Seed Performance of Ipk1 Mutant
Compared to the wild type and the parental ipk1-1 mutant, the transgenic lines expressing the Gle1 variants were evaluated for a seed weight, a seed yield and a seed germination frequency. There were no apparent differences in seed morphology between these lines (
However, GFP-IS1 and GFP-IS2 plants had seed yields which were comparable to or even higher than the wild-type level. Meanwhile, the GFP-Gle1 plant showed only a slightly increased seed yield compared to the ipk1-1 mutant (
It has been reported that a seed phytate level was reduced to about 83% of the ipk1-1 mutant (Stevenson-Paulik et al., 2005). The inventors performed a high-performance ion chromatography (HPIC) analysis on water soluble extracts from mature dried seeds to measure seed phytate content in the transgenic plants (
Experimental Result 9. IPK1 Interacts with LOS4, but not with Gle1, in Nuclear Envelope and Cytosol
In mature seeds, phytic acid accumulates in protein storage vacuoles (PSV) as stable salts (phytins) by binding to mineral cations (Lott, 1995). It was suggested that phytic acid is synthesized in association with the endoplasmic reticulum (ER), transferred to ER lumen, and then transported to vesicles of PSV in developing seeds (Otegui et al., 2002). However, there was almost no experimental evidence relating to the synthesis and transport of phytic acid in plants. Thus, the inventors investigated the subcellular localization of IPK1 of Arabidopsis by GFP fusion. Confocal microscopy detected IPK1-GFP fluorescence mainly in the cytosol and around the nuclear envelope (
[Discussion]
In yeast, plants and mammals, Gle1 is a component for NPC, but is also present in the cytosol. In the present invention, the inventors investigated the nuclear function of Gle1 in plants, and developed a novel technique for reducing the adverse effect of the low-phytate characteristic using Gle1 variants. Plant Gle1 is involved in mRNA export in the nucleus by interacting with LOS4 to stimulate LOS4 ATPase activity. Functions of Gle1 are essential for embryogenesis (Braud et al., 2012), and critical for the postembryonic growth of plants (
Although detailed mechanisms of Gle1 and LOS4 in an mRNA export pathway in plants remain to be determined, the results of the present invention suggest that the DEAD-box ATPase/RNA helicase LOS4 is activated by Gle1 in a similar manner as described for the Dbp5 activation in yeast. However, the requirement of Gle1 for a co-activator InsP6 seems to be different between yeast and plants. In yeasts, the addition of InsP6 (100 nM) to Gle1 and RNA causes an additional 3- to 4-fold increase in Dbp5 ATPase activity (Dossani et al., 2009; Montpetit et al., 2011), and 30% additional increase in LOS4 activity in plants even at higher InsP6 (10 μM) concentrations (
However, Gle1 may directly interact with LOS4 in vitro, and Gle1 only may stimulate LOS4 activity in the absence of InsP6 (
InsP6 has been shown to possess a diverse set of cellular functions, including mRNA export, translation control, chromatin remodeling, RNA editing, and DNA repair, in yeast and mammals (Hanakahi and West, 2002; Shen et al., 2003; Macbeth et al., 2005; Bolger et al., 2008; Montpetit et al., 2011). In plants, InsP6 has been associated with auxin signaling, an ABA reaction in guard cells and plant defense reactions by binding to the auxin receptor TIR1 (Lemtiri-Chlieh et al., 2000; Tan et al., 2007; Murphy et al., 2008). In yeast, the Δipk1 mutation abolished InsP6 accumulation and caused synthetic lethality combined with alleles of Gle1, Dbp5 and Nup159 (Miller et al., 2004; Weirich et al., 2004; Weirich et al., 2006). IPK1−/− variant mice died during early embryogenesis, showing the importance of InsP6 for early embryogenesis of mammals. However, their heterozygous littermates developed normally with normal cellular InsP6 levels and elevated InsP5 levels (Verbsky et al., 2005). The ipk1-1 mutation in Arabidopsis, which caused >70% decrease in IPK1 mRNA levels, caused stunted growth, and reduced seed yields and abnormal seed germination (
To solve the nutritional and environmental problems related to dietary seed phytic acid, various approaches have been used to cultivate low-phytate crops. However, since the synthetic pathway of phytic acid is associated with various cellular pathways of plants, low-phytic acid (lpa) mutant crops showed defects in seed yields, seed weights, germination and emergence, stress responses and disease susceptibility (Raboy et al., 2000; Raboy, 2001, 2009; Meis et al., 2003; Pilu et al., 2005; Bregitzer and Raboy, 2006; Murphy et al., 2008). To avoid such adverse effects, seed-specific targeting of the low-phytate characteristic has been used more recently. Silencing of a gene for phytic acid metabolism using a seed-specific promoter or seed-specific expression of microbial phytases led to low-phytate levels of seeds in maize, rice, wheat, and soy bean (Drakakaki et al., 2005; Shi et al., 2007; Bilyeu et al., 2008; Kuwano et al., 2009; Ali et al., 2013; Li et al., 2014). However, undesirable effects such as defects in seed weight, germination frequency and seedling emergence were still observed in several trials (Bilyeu et al., 2008; Kuwano et al., 2009; Li et al., 2014). Such controversial results may be caused by differences in reduction of phytic acid in seeds used in the present invention, the identities, genes, and promoters of plant species, and disturbance of phosphorus homeostasis in such plants. Therefore, development of high yield low-phytate crops seems to be attempted due to unexpected downstream effects of the InsP6 defect.
The inventors developed a new technique for reducing adverse effects of the low-phytate characteristic on plant growth, seed yield, and seed germination by rescuing the mRNA export defect of the InsP6-deficient ipk1 mutants using InsP6 sensitivity-increased Gle1 variants. Introduction of IS1 and IS2 variants into low-phytate crops may improve seed yields and seed performance by eliminating impediments such as the mRNA export defect and other Gle1/InsP6-derived defects, and will become the basis for the development of high yield, low-phytate and continuously grown seed crops.
Features and advantages of the present invention are summarized as follows:
First, the inventors identified that Gle1, as well as InsP6, serves as an activator of a LOS4 ATPase/RNA helicase for mRNA export in plants.
Meanwhile, Gle1 variants with mutations to increase a basic charge on an InsP6-binding surface show increased sensitivity to InsP6 concentrations for the stimulation of LOS4 ATPase activity in vitro.
In addition, expression of the Gle1 variants with the increased InsP6 sensitivity rescues the mRNA export defect caused by ipk1 InsP6-deficient mutation, thereby highly increasing vegetative growth, seed yield, seed performance and tolerance to abiotic stresses of the mutant.
This indicates that Gle1 is a major factor responsible for mediating an InsP6 function in plant growth and reproduction, and the expression of the Gle1 variants can be a strategy that can cultivate high yield low-phytate crops by reducing the adverse effects of the low-phytate multination.
From above, specific parts of the present invention have been described in detail. However, it will be apparent to those of ordinary skill in the art that such detailed descriptions are just exemplary embodiments, and thus the scope of the present invention is not limited thereto. Therefore, the actual range of the present invention will be defined by the accompanying claims and equivalents thereof.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2015-0007246 | Jan 2015 | KR | national |
This application claims priority to and the benefit of Korean Patent Application No. 2015-0007246, filed on Jan. 15, 2015 and International Patent Application No. PCT/KR2016/000481, filed on Jan. 15, 2016, the disclosure of which is incorporated herein by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/KR2016/000481 | 1/15/2016 | WO | 00 |
